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Objective: Males with chronic obstructive pulmonary disease (COPD) are at increased risk for
developing osteoporosis (OP) with subsequent vertebral compression fractures. Such fractures
with resultant increased thoracic kyphotic angle (TKA) may interfere with these patients’ al-
ready compromised pulmonary function. A retrospective cross-sectional study was performed
to evaluate the recognition and treatment of vertebral fractures in male patients with COPD.
Methods: The study population included male patients with COPD aged 55 years and older who
had a lateral chest X-ray (index film) performed between January 1, 2001 and July 5, 2005.
Vertebral fractures and the TKA were determined independently by two different radiologists.
One radiologist (reviewer #1) used direct measurement including quantitative morphometric
analysis to determine fractures and the TKA, whereas the second radiologist (reviewer #2) used
visual inspection only. Inter-reader agreement for vertebral fractures and TKA was assessed.
The computerized charts were reviewed to determine the initial recognition of vertebral
fractures and the subsequent therapy. Logistic regression was employed to determine signifi-
cant risk factors for vertebral fractures in this male population.
Results: Three hundred and fifty male study subjects and their index lateral chest X-rays were
reviewed. Ages ranged from 52 to 90 and 9/350 (2.6%) of the study subjects had vertebral frac-
tures identified on the initial radiology report. None of these nine patients were subsequently
treated with anti-osteoporotic agents other than calcium and vitamin D, and two of them had
a follow-up central bone density. Reviewer #1 measured 361 fractures in 181 subjects and
determined the mean TKA to be 31.43 (8.62) degrees. Reviewer #2 identified 27 fractures
in 19 subjects and with an estimated mean TKA of 24.84 (8.53) degrees. There was little974 2681.
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1166 J.D. Carter et al.inter-observer agreement with vertebral fractures (kappaZ 0.07), but there was a strong pos-
itive correlation with the TKA (rZ 0.79). There was a weak to moderate correlation with the
TKA and the presence of vertebral fractures (rZ 0.26). Significant risk factors for vertebral
fractures included smoking status (odds ratio 1.84 [1.08e3.15]) and age (odds ratio 1.06
[1.03e1.09] for each year increase in age).
Conclusion: A large number of vertebral fractures in males with COPD goes undiagnosed. In
those patients with diagnosed vertebral fractures, follow-up therapy is under-utilized. When
analyzing lateral chest X-rays for vertebral fractures, visual inspection alone without direct
measurement may not be an adequate technique for identifying fractures.
ª 2008 Elsevier Ltd. All rights reserved.Male osteoporosis is a growing problem that frequently goes
undiagnosed.1,2 Certain male patient populations are at
increased risk for developing osteoporosis. One such group
is men with chronic obstructive pulmonary disease (COPD)
because of risk factors including corticosteroid use and
significant smoking history.3,4 A recent analysis suggested
that the prevalence of osteoporosis and fractures is
increased even in newly diagnosed COPD patients.5 Verte-
bral compression fractures can significantly impact morbid-
ity and mortality in all patients,6,7 but particularly in this
patient population.8 Symptomatic compression fractures
may interfere with these patients’ already compromised
pulmonary function, thus adding to their morbidity and
possibly mortality. The increased thoracic kyphotic angle
(TKA) that is associated with vertebral compression frac-
tures has been shown to decrease the forced vital capacity
and forced expiratory volume in 1 s in patients.9
Recognition of vertebral compression fractures is para-
mount since these are a strong predictor of future fractur-
es.10e12 In addition, appropriate medications can decrease
the incidence of these future fractures.13e16 There are less
data regarding the therapeutic effect of anti-osteoporotic
therapy in males, specifically. However, data exist to sug-
gest a beneficial effect.14 Vertebral compression fractures
often go undetected either because they are asymptom-
atic, undiagnosed, or felt to be part of the normal aging
process.17e19 Under-diagnosis most likely represents a big-
ger concern in males. Because our therapies also decrease
the incidence of future fractures in those at increased risk,
it is also very important to recognize those individuals.
The interpretation of chest X-rays in the setting COPD
focuses on lung pathology, whereas the musculoskeletal
system is often overlooked. At best a visual inspection for
vertebral compression fractures is performed. However,
objective signs of vertebral fractures can be quantified by
morphometric analysis. The majority of previous data
suggest a correlation between semi-quantitative technique
(visual inspection followed by visual approximation of
height loss) and quantitative morphometric assessment of
vertebral fractures,20e22 yet other data suggest a poorer
correlation.23 Studies that have analyzed the correlation
of visual inspection alone (without any direct quantitative
assessment) with semi-quantitative or quantitative analysis
reveal even less agreement.24,25 Therefore, even when
focused visual inspection occurs, many vertebral fractures
remain undiagnosed.
It has been estimated that the prevalence of vertebral
compression fractures is 13.1% for women over the age of
65.26 We felt that a conservative estimate would be thatthis high-risk population of males would be at equal risk
for vertebral compression fractures to post-menopausal
females. In order to evaluate the recognition and treat-
ment of vertebral compression fractures and osteoporosis
in male patients with COPD, we evaluated lateral chest
X-rays that were obtained as part of the routine care of
male patients with COPD. We also evaluated the radiology
reports, clinic notes and associated work-up to analyze
the treatment of this group of patients at increased risk
for osteoporosis and its pathologic sequelae.
Methods
Study subjects
Study subjects were randomly generated from the comput-
erized patient record system (CPRS) at the James A. Haley
Veterans Affairs Hospital (JAHVA) in Tampa, Florida, which
has approximately 94% male enrollees. The computer
generated list randomly selected appropriate study candi-
dates from the time frame of January 1, 2001 until July 1,
2005. There are approximately 600,000 outpatient visits
yearly at this facility. The inclusion criteria were: male sex,
age 55 or greater, diagnosis of COPD, and a lateral chest
X-ray obtained for a symptomatic COPD episode. The
exclusion criteria were: serum creatinine of >2.5 mg/DL
(at any time), a history of ankylosing spondylitis, Scheuer-
mann’s disease, or any previous spinal surgery.
All data were abstracted from the CPRS. This electronic
medical record includes all of the progress notes (including
emergency room visits), medication lists, imaging reports,
and inpatient records with discharge summaries. The bone
densitometry scanner used at this facility is a LUNAR GPX DXA.
A cross-sectional retrospective computerized chart
review was approved by the Veterans Affairs Research
Compliance Committee and the University of South Florida
Institutional Review Board. Confidentiality in accordance
with the Health Insurance Portability and Accountability
Act of 1996 was maintained by assigning each study subject
(and their lateral chest X-ray) a code. The code was
destroyed upon completion of data entry. The computer
generated list provided 350 random study subjects who met
the above criteria.
Data collection
The CPRS was reviewed on each of the 350 study subjects
from the date of the index lateral chest X-ray through July
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JAHVA. Data collected on each study subject at the time of
their index film included their age, weight, height, smoking
status, alcohol status, and years since diagnosis of COPD.
Their current and past use of oral corticosteroids was also
recorded and quantified (previous review of corticosteroid
use was performed as far back as January 1, 2000). The
official radiology report from each index lateral chest X-ray
was reviewed specifically to see if any vertebral fractures
were noted. The medication lists were reviewed from the
time of the index film until July 1, 2005 to evaluate for any
subsequent anti-osteoporotic treatment. The medications
abstracted included alendronate, risedronate, pamidro-
nate, etidronate, calcitonin (nasal or injectable), teripara-
tide, and testosterone. Any use of calcium and vitamin D
were recorded in the study period. Finally, any central
bone density (DXA) performed on the study subjects after
their index lateral chest X-ray were recorded.
Each of the 350 lateral chest X-rays was independently
evaluated by two board certified radiologists in random
order. There was no accompanying clinical information
given to the radiologists. One of the radiologists (reviewer
#1) specializes in musculoskeletal radiology and the other is
a general radiologist (reviewer #2). Each radiologist was
instructed to inspect the lateral chest X-rays for the
presence of vertebral fractures. They attempted to evalu-
ate all of the thoracic vertebrae from T1 to T12. Reviewer
#1 interpreted the films using visual inspection that was
followed by direct quantitative morphometric analysis of
the abnormal appearing vertebral body heights and area for
confirmation. The measurement of height reduction could
be performed at the anterior, posterior, or middle of the
vertebral body. Any loss of height were compared to
adjacent vertebral bodies. Reviewer #2 used the method
described by Genant et al.,27 i.e. a visual inspection
followed by visual approximation of vertebral body percent
height loss. Each vertebral body was given a score of 0e3.
A score of 0 was normal, 1 was equivalent to a grade 1 de-
formity (20e25% reduction in height and 10e20% reduction
in area), 2 was a grade 2 deformity (25e40% reduction in
height and 20e40% reduction in area), and 3 was a grade
3 deformity (>40% reduction in height or area). Each radi-
ologist was also instructed to determine the thoracic
kyphotic angle (TKA) on the lateral film. Reviewer #1
directly measured the TKA by using the modified Cobb tech-
nique28,29; and reviewer #2 estimated the TKA by visual
inspection only. The modified Cobb technique is performed
by drawing parallel lines to the superior border of T3
vertebral body and inferior border of T12; a perpendicular
line is drawn to each endplate line and the angle at the
intersecting lines is measured with goniometry.
Statistical analysis
Our sample size was determined by using the estimation
that 13% of the study subjects would have vertebral
compression fractures on their index films and that 1.6%
of the entire study population would be started on anti-
osteoporotic medication as a result of their index film. The
1.6% were determined by estimating that 50% of the
compression fractures would be noted in the radiology
reports, and of those noted 50% would be addressed in theprogress notes, of which 50% would ultimately receive
treatment [i.e. 13% 50% 50% 50%Z 1.6%].17 Based on
these estimates, our sample size was 328 study subjects
(with 95% power and 0.05 alpha). We decided to review
350 study subjects to compensate for any potential missing
data.
Study subject demographic data were analyzed in the
standard fashion. Radiologist inter-observer agreement was
assessed by the use of a 2 2 table as well as determining
kappa statistic measurement. Kappa is an index which
compares the agreement against that which might be
expected by chance. This inter-reader agreement was
also analyzed by the grade of the fracture. The determina-
tion of inter-observer agreement on the TKA was deter-
mined by constructing a scatterplot and determining the
Spearman rank test and a paired t-test. The point biserial
correlation test was also used to assess if there was a corre-
lation between the TKA and the presence of vertebral
fractures. The Pearson product-moment correlation test
was used to assess the relationship between the TKA and
the spinal deformity index (SDI), which is the summation
of fractures grades for each subject. Finally, logistic regres-
sion was employed to determine which risk factors lead to
a greater likelihood of vertebral fracture. The covariates
considered for the model were age, smoking and alcohol
status, corticosteroid use (current or previous), and previ-
ous treatment with calcium and vitamin D.Results
The computer randomly generated a list of 350 males who
had a lateral chest X-ray performed at the JAHVA for
a symptomatic COPD episode between January 1, 2001 and
July 1, 2005. The search criteria excluded males younger
than the age of 55, however, this was based on the day of
the random computer generated list (July 16, 2005).
Therefore, the minimum age was 52 at the time of the
index film; the maximum age was 90. The lateral chest
X-rays were obtained on all 350 subjects. The mean age was
68.2 years, with the mean height and weight being
175.8 cm (69.2 in) and 89.3 kg (196.4 lbs), respectively
(see Table 1). Because the CPRS was first utilized in 1999
at the JAHVA, we were able to obtain data regarding the
duration since their COPD diagnosis in 180 of the subjects;
the average time since their diagnosis was 5 years.
Thirty-five percent of the subjects were current smokers
and 48% were current drinkers (Table 1). Only 4% of the
subjects were on corticosteroids at the time of their index
chest X-ray, but 38% had used corticosteroids at some point
between January 1, 2001 and the time of their index chest
X-ray (Table 2).
Nine of the study subjects (2.6%) were reported to have
vertebral compression fractures in the official report from
their index chest X-ray. Five of these reports specified the
involved vertebral body when one was involved. In the four
reports that indicated multiple fractures, the specific sites
were not mentioned. None of the fractures were graded.
Interestingly, 63 (18%) of the radiology reports mentioned
some type of degenerative changes in the spine. Five
different subjects with rib fractures were noted. The
radiology report could not be located on one subject.
Table 1 Study subject demographics
Mean Range Standard
deviation
#
Age 68.2 years 52e90 years 8.58 years 350
Height 175.8 cms 147.3e223.5 cms 7.9 cms 349
Weight 89.3 kgs 41.8e163.6 kgs 21.6 kgs 348
COPD disease duration 5.0 Years 1 Monthe24 years 4.8 Years 180
Current smoker (102/292; 35% of study subjects) 1.34 ppd <1e3 ppd 0.76 ppd 292
Current drinker (165/344; 48% of study subjects) 1.97 dpd 1e12 dpd 2.5 dpd 344
ppdZ packs per day; dpdZ drinks per day.
1168 J.D. Carter et al.Three of the nine subjects with vertebral fractures on
their radiology reports had the fracture/s addressed in their
subsequent clinic notes. Three of the subjects with
fractures were prescribed calcium and vitamin D and
a central bone density (DXA) was obtained on two. None
of the subjects with vertebral fractures on their radiology
reports were started on anti-osteoporotic therapy other
than calcium and vitamin D.
Of the 350 study subjects, 37 (10.6%) were treated with
either calcium (19/37) or calcium and vitamin D (18/37).
Nineteen of the 350 subjects (5.4%) were treated with an
anti-osteoporotic agent (Table 3).
Reviewer #1 reported a total of 361 fractures in 181
patients, while reviewer #2 only reported 27 fractures in 19
different patients. The 2 2 table (Table 4) shows the
frequency of patients with or without fractures as deter-
mined by the two reviewers. The observed proportion of
overall agreement is 52%. This is obtained by summing cells
‘‘A’’ and ‘‘D’’ then dividing the total of 350 patients. This
may be inflated due to the fact that one reviewer reported
very few fractures overall thus making cell ‘‘A’’ in the
2 2 table large (cell ‘‘A’’ represents no fracture reported
by either reviewer). The proportions of specific agreement
for ‘‘Yes’’ ratings and ‘‘No’’ ratings are 16% and 66%, respec-
tively. The proportion of specific agreement for the YeseYes
category is very low, which indicates poor agreement.
Another measure of agreement, kappa was calculated
from the 2 2 table. Kappa can be thought of as the
chance-corrected proportional agreement, and possible
values range from þ1 (perfect agreement) via 0 (no agree-
ment above that expected by chance) to 1 (complete
disagreement). The kappa value for this table is 0.07.Table 2 Oral corticosteroid usage
Yes
Current corticosteroid users 15 (4%)
Previous corticosteroid users
(from January 1, 2001 e date of chest X-ray)
128 (38%
Average corticosteroid daily dose Low (<5
Current corticosteroid users (#Z 15) 1
Previous corticosteroid users (#Z 128) 105
Note: This table includes only oral corticosteroid usage. Inhaled cort
glucocorticoid users fall into the ‘‘low’’ category because of infrequeTable 5 shows the distribution of the reported fractures
by each reviewer broken down by the grade of fracture. Of
the 350 patients 155 had grade 1 fractures. A total of 263
grade 1 fractures were reported by the reviewers. The
reviewers agreed on only four of the 155 patients. A total
of 102 grade 2 fractures were reported by the reviewers
found in 78 patients. The reviewers only agreed on one
fracture. A total of 23 grade 3 fractures were reported in
15 patients. The reviewers agreed on four patients. The
location of the fractures reported (T1eT12) is listed in
Table 6.
Due to the low inter-reader agreement of all fractures,
inter-reader agreement was also assessed using only grade
2 or 3 fractures. Reviewer #1 reported 115 grade 2 or 3
fractures while reviewer #2 reported only 10. Similar to the
inter-reader assessment of all fractures, the kappa value
approached zero. However, this assessment might be low
considering it analyzed agreement in both the presence and
grade of fracture.
Each reviewer noted the TKA for each study subject. The
mean TKA for reviewer #1 was 31.43 (8.62) degrees and
for reviewer #2 was 24.84 (8.52) degrees. The scatterplot
of the TKA measurements is shown in Fig. 1. There is a pos-
itive correlation between the TKA reported by the two
reviewers (rZ 0.79). The Spearman rank test was used to
evaluate the statistical significance of the correlation,
which yielded a p-value< 0.0001. The point biserial
correlation between the TKA and the presence of fractures
is 0.26. This value is statistically different from zero at the
5% level of significance (alphaZ 0.05) with a p-value
< 0.0001. A correlation of 0.26 is considered as a small to
moderate correlation. We also examined the correlationNo #
332 (96%) 347
) 212 (62%) 340
mg/day) Intermediate
(5e10 mg/day)
High (>10 mg/day)
7 7
20 3
icosteroid usage data were not abstracted. Most of the previous
nt short courses of glucocorticoids.
Table 5 Number of fractures reported by reviewer by
grade
Grade of fracture
1 2 3
Reviewer #1 246 99 16
Reviewer #2 17 3 7
Table 6 Location of fractures by reviewer
Reviewer #1 Reviewer #2
T1 0 0
T2 0 0
T3 7 0
T4 6 1
T5 13 1
Table 3 Therapy and evaluation for study subjects
#
Calciuma 19 (5.4%)
Calcium and vitamin Da 18 (5.1%)
Alendronate 5 (1.4%)
Risedronate 1 (0.3%)
Calcitonin 1 (0.3%)
Testosteroneb 12 (3.4%)
DXA 19 (5.4%) [8 normal;
5 osteopenia;
5 osteoporosis]c
a Thirty-seven out of 350 (10.6%) of subjects treated with
calcium vitamin D.
b Might have been prescribed primarily for hypogonadism
rather than osteoporosis.
c Based on the worst T-score (T-scores not available for one
patient).
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by adding the fracture grades of all vertebrae for each
patient, with the TKA. The Pearson product-moment
correlation between the TKA and the SDI is equal to 0.34
and 0.26 for reviewers #1 and #2, respectively (both small
and moderate).
Logistic regression was employed to determine which
factors lead to a greater chance of fractures (any grade
fracture was included in the analysis). Covariates consid-
ered for the model were smoking status, alcohol use status,
duration since diagnosis, age, treatment with calcium or
vitamin D, and steroid use. Smoking status and age were
the only two significant factors. The probability that a sub-
ject will have a fracture according to the model can be
written as
pðfractureÞZ e
4:0199þ0:6099ðsmokerÞþ0:05627ðageÞ
1þ e4:0199þ0:6099ðsmokerÞþ0:05627ðageÞ:
The odds ratio for smoking status is 1.84 (95% confidence
interval [CI] 1.08e3.15). The ratio of odds for a one unit
change in age is 1.06 (95% CI 1.03e1.09). So for men aged
52e90 for each year increase in age there is a 1.06 greater
chance of any fracture (or 1.75/decade). The p-value for
previous or current corticosteroid use is 0.65. The same
logistic regression model was repeated using only patients
with grade 2 and 3 fractures with very similar findings
(data not shown).
Because of the low inter-reader agreement for frac-
tures, a random sample of 40 of the 350 original chest
X-rays was re-read by each radiologist to assess intra-
reader agreement. Each radiologist used the same tech-
nique utilized with their initial reading and the analysis wasTable 4 Number of subjects with fractures by reviewer
Reviewer #1
No Yes
Reviewer #2 No 166 165
Yes 3 16restricted to grade 2 and 3 fractures. The intra-reader
kappa value for reviewer #1 was 0.60 which indicates
substantial intra-reader agreement. Regarding reviewer
#2, the sample size was not large enough to determine
a kappa value, however, this reviewer reported a total of 3
grade 2 or higher fractures on the initial reading and 4 on
the re-read. The intra-reader kappa value for reviewer #2
for all fractures was 0.53 which indicates moderate to
substantial intra-reader agreement.
Discussion
These data strongly suggest that a large number of
vertebral compression fractures in males are not diagnosed
on chest X-rays that are obtained because of a symptomatic
COPD episode. The reasons are probably multi-factorial
including a low index of suspicion in routine clinical care,
a higher index of suspicion in this study, and lung pathology
being the primary focus of interest on these initial radio-
graph readings. Traditionally, the pathologic sequelae of
osteoporosis are most often considered in female patients.
Because of the high incidence of fractures, this study
highlights the importance of risk factors other than female
gender. The two significant risk factors in this study were
tobacco use and age. Because the CPRS system was first
utilized in 1999 at our institution, it was very difficult to
obtain a tobacco history in the years prior to the index
chest X-ray. Although a majority of COPD patients have
a smoking history, current tobacco use (with the ranges
described in Table 1) still afforded a significant risk of
radiographic fractures. Interestingly, glucocorticoids did
not afford a significant risk. This finding concurs withT6 22 3
T7 46 3
T8 69 10
T9 51 4
T10 23 1
T11 60 3
T12 64 1
Total 361 27
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Figure 1 Scatterplot of kyphotic angle (rZ 0.7899,
p-value< 0.0001).
1170 J.D. Carter et al.a recent study demonstrating that intermittent high-dose
glucocorticoids with a cumulative exposure of 1 g pose
only a small risk of osteoporotic fractures.30
Although it is clear that vertebral fractures were under-
diagnosed in the official radiology reports, the osseous
structures were not totally neglected. Nearly one in five of
the official reports mentioned some type of degenerative
changes. Nearly half (30/63) of the reports that described
degenerative changes also described that no fractures were
noted. Therefore, the majority of the reports under-
diagnosing vertebral fractures gave no description of the
osseous structures at all.
The numbers were too small (nine subjects) to
determine the effectiveness of osteoporosis treatment in
those subjects whose official radiology report mentioned
vertebral fractures, but none of these patients were on
anti-osteoporotic therapy other than calcium and vitamin
D. The American College of Rheumatology guidelines for
glucocorticoid-induced prevention (GIOP) suggest that
patients on chronic steroid doses of >5 mg daily (of predni-
sone or its equivalent) should be prescribed prophylactic
therapy.31 Further, any patient with known vertebral com-
pression fractures requires treatment.12,13,15,16 Using these
guidelines, 31/350 (8.9%) [23 GIOP and eight with reported
fractures {one subject met both criteria}] patients should
have been on some type of anti-osteoporotic therapy. Nine-
teen out of 350 (5.4%) subjects in our database were
treated. However, the latter could be inflated because
the majority of these were on testosterone, possibly for
reasons other than OP. Only six subjects (1.7%) were on a bi-
sphosphonate, which are considered the mainstay of GIOP.
Radiologists in clinical practice are forced with the
burden of a high work-load and the demand for detailed
accuracy. This is a challenging task. In this study, both
radiologists (reviewers #1 and #2) were instructed to look
for vertebral fractures and determine the TKA; however,
one used direct measurement and the other visual
inspection only. Reviewer #2 was meant to simulate
a ‘‘real-world’’ visual inspection for vertebral fractures.
Although both reviewers reported more vertebral compres-
sion fractures than the official reading, there was little
inter-reader agreement. Therefore, focused visual inspec-
tion alone does not appear to be an adequate technique atdiscovering vertebral compression fractures. Conversely,
there was a high degree of inter-reader agreement
regarding the TKA. Although previous studies have pro-
duced conflicting results regarding the correlation with TKA
and vertebral fractures,29,32,33 our study suggests there is
a correlation between these two variables. There was a sim-
ilar association with the TKA and the SDI. These data
suggest that determination of the TKA by visual inspection
followed by direct measurement for fractures might be the
most accurate and time efficient technique. Further studies
in this regard would be useful.
Although anti-osteoporotic therapy and the use of DXA’s
in this study were low, any data that were not in the CPRS
were not analyzed. In particular, it is possible that the use
of calcium and vitamin D was under-represented since this
is not a prescription therapy. Also, any DXA’s that might
have been obtained outside of the VA system were not
recorded. Nonetheless, osteoporosis evaluation and treat-
ment were clearly under-utilized.
The difference in fracture prevalence reported by
reviewer #1 vs. reviewer #2 was greater than anticipated,
yet it was not the primary aim of this study to compare the
correlation of quantitative analysis vs. qualitative visual
inspection. The vast majority of the difference pertained to
grade 1 fractures. Of note, 246/361 (68%) of fractures
reported by reviewer #1 were grade 1 fractures. At times,
degenerative changes of vertebral bodies can appear
similar to mild (grade 1) compression fractures thereby
leading to over-diagnosis of fractures. Therefore, this could
be the primary explanation for the low inter-reader
agreement. However, there was also a discrepancy in the
reporting of grade 2 and 3 fractures. Why the difference
was so large is not entirely clear, but the technique utilized
is another explanation. Although the grading system by
Genant et al. is specific, the determination of the fracture
grade is still somewhat subjective. For example, if an
entire vertebra appears to be mildly compressed, the
original height of the vertebral body must be estimated in
order to determine the percentage of collapse. Also,
morphometric analysis might lead to misdiagnosis of
degenerative changes as fractures. Further, not all thoracic
vertebrae are easily visible on a lateral chest X-ray and on
occasion they cannot be reliably numbered secondary to
too many or non-visualized ribs. It is also possible that the
extra time required performing direct measurement by
reviewer #1 allowed for a more thorough search. Finally,
reviewer #1 is a musculoskeletal radiologist and reviewer #2
is a general radiologist possibly explaining some of the
difference. This could have important clinical implications
in that the majority of chest X-rays are read by general
radiologists. Nonetheless there was a clear difference
between these techniques. The fact that grade 2 and 3
fractures were also differentially reported has potential
important clinical implications relating to ‘‘real-world’’
clinical practice since these fractures portend higher
morbidity, mortality, and fracture prediction. This high-
lights the importance of careful direct measurement in
order to detect all occult vertebral fractures.
It is important to note that these data were obtained at
one center using two radiologists. The general applicability
of these data could be questioned. Previous studies have
yielded mixed results regarding radiologist inter-observer
Recognition and treatment of vertebral fractures 1171agreement when interpreting radiographs for the presence
of vertebral fractures. Many of the data suggest that reader
inter-reader agreement is good,20e22 but other data dictate
that 30e47% of all radiographs with vertebral fractures go
undetected even when the validated semi-quantitative
method is utilized.23 Inter-reader agreement is particularly
poor when different techniques are utilized when reading
these radiographs. When qualitative visual identification
was compared to the more objective semi-quantitative
method the agreement was poor with far fewer fractures
detected by the qualitative approach in general24 or using
vertebral height only.25 Therefore, it is not surprising that
our study revealed poor agreement between radiologists,
particularly since they utilized different techniques to
identify fractures. This further suggests that the ‘‘real-
world’’ practice of qualitative visual identification of
vertebral fractures leaves many fractures undiagnosed.
Reviewer #1 determined that 51.7% (181/350), 22.3%
(78/350), and 6.6% (23/350) of the subjects in this study
had at least one grade 1, 2, or 3 vertebral compression
fracture, respectively. Only 2.6% (9/350) of the subjects
had fractures identified on their original radiology report.
Even qualitative visual inspection (reviewer #2) detected
far more vertebral fractures than was originally reported.
Given the added morbidity of such fractures (particularly if
they are symptomatic) in this patient population, osteopo-
rosis and its sequelae need to be in the forefront of any
therapeutic decision-making in patients with COPD. It is
also evident that we need to be more vigilant in our search
for occult vertebral fractures in male patients with COPD.
Conflict of interest statement
There are no other potential conflicts of interest with any
of the authors in relation to this work.
Acknowledgment
This research was supported by an investigator initiated
grant from Merck.
References
1. Eastell R, Boyle IT, Compston J, Cooper C, Fogelman I,
Francis RM, et al. Management of male osteoporosis: report
of the UK consensus group. QJM 1998;91(2):71e92.
2. Olszynski WP, Shawn Davison K, Adachi JD, Brown JP,
Cummings SR, Hanley DA, et al. Osteoporosis in men; epidemi-
ology, diagnosis, prevention, and treatment. Clin Ther 2004;
26(1):15e28.
3. McEvoy CE, Ensrud KE, Bender E, Genant HK, Griffith JM,
Niewoehner DE. Association between corticosteroid use
and vertebral fractures in older men with chronic obstruc-
tive pulmonary disease. Am J Respir Crit Care Med 1998;
157(3 Pt 1):704e9.
4. Papaioannou A, Parkinson W, Ferko N, Probyn L, Ioannidis G,
Jurriaans E, et al. Prevalence of vertebral fractures among pa-
tients with chronic obstructive pulmonary disease in Canada.
Osteoporos Int 2003;14(11):913e7.
5. Soriano JB, Visick GT, Muellerova H, Payvandi N, Hansell AL.
Patterns of comorbidities in newly diagnosed COPD and asthma
in primary care. Chest 2005;128(4):2099e107.6. Yuan HA, Brown CW, Phillips FM. Osteoporotic spinal defor-
mity: a biomechanical rationale for the clinical consequences
and treatment of vertebral body compression fractures.
J Spinal Disord Tech 2004 Jun;17(3):236e42.
7. Truumees E. Medical consequences of osteoporotic vertebral
compression fractures. Instr Course Lect 2003;52:551e8.
8. Jorgensen NR, Schwarz P, Holme I, Henriksen BM, Petersen LJ,
Backer V. The prevalence of osteoporosis in patients with
chronic obstructive pulmonary disease: a cross sectional study.
Respir Med 2007 Jan;101(1):177e85.
9. Lombardi Jr I, Oliveira LM, Mayer AF, Jardim JR, Natour J.
Evaluation of pulmonary function and quality of life in women
with osteoporosis. Osteoporos Int 2005 Oct;16(10):1247e53.
10. Ross PD, Davis JW, Epstein RS, Wasnich RD. Pre-existing
fractures and bone mass predict vertebral fracture incidence
in women. Ann Intern Med 1991;114:919e23.
11. Ross PD, Genant HK, Davis JW, Miller PD, Wasnich RD. Predicting
vertebral fracture incidence from prevalent fractures and bone
density among non-black, osteoporotic women. Osteoporos Int
1993;3:120e6.
12. Lindsay R, Silverman SL, Cooper C, Hanley DA, Barton I,
Broy SB, et al. Risk of new vertebral fracture in the year fol-
lowing fracture. JAMA 2001;285(3):320e3.
13. Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE,
Nevitt MC, et al. Randomised trial of the effect of alendronate
on risk of fracture in women with existing vertebral fractures.
Fracture Intervention Trial Research Group. Lancet 1996;
348(9041):1535e41.
14. Gonnelli S, Cepollaro C, Montagnani A, Bruni D, Caffarelli C,
Breschi M, et al. Alendronate treatment in men with primary
osteoporosis: a three year longitudinal study. Calcif Tissue
Int 2003;73(2):133e9.
15. Harris ST, Watts NB, Genant HK, McKeever CD, Hangartner T,
Keller M, et al. Effects of risedronate treatment on vertebral
and nonvertebral fractures in women with postmenopausal
osteoporosis: a randomized clinical trial. JAMA 1999;282:
1344e52.
16. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA,
Reginster JY, et al. Effect of parathyroid hormone (1e34) on
fractures and bone mineral density in postmenopausal women
with osteoporosis. N Engl J Med 2001;1344(19):1434e41.
17. Gehlbach SH, Bigelow C, Heimisdottir M, May S, Walker M,
Kirkwood JR. Recognition of vertebral fracture in a clinical
setting. Osteoporos Int 2000;11(7):577e82.
18. Kim N, Rowe BH, Raymond G, Jen H, Colman I, Jackson SA,
et al. Underreporting of vertebral fractures on routine chest
radiography. AJR Am J Roentgenol 2004;182(2):297e300.
19. Majumdar SR, Kim N, Colman A, Chahal AM, Raymond G, Jen H,
et al. Incidental vertebral fractures discovered with chest radi-
ography in the emergency department: prevalence recogni-
tion, and osteoporosis management in a cohort of elderly
patients. Arch Intern Med 2005;165(8):905e9.
20. Genant HK, Jergas M, Palermo L, Nevitt M, Valentin RS,
Black D, et al. Comparison of semiquantitative visual and quan-
titative morphometric assessment of prevalent and incident
vertebral fractures in osteoporosis. The Study of Osteoporosis
Fractures Research Group. J Bone Miner Res 1996;11(7):
984e96.
21. Wu CY, Li J, Jergas M, Genant HK. Comparison of semiquanti-
tative and quantitative techniques for the assessment of
prevalent and incident vertebral fractures. Osteoporos Int
1995;5(5):354e70.
22. Black DM, Palermo L, Nevitt MC, Genant HK, Epstein R, San
Valentin R, et al. Comparison of the methods for defining prev-
alent vertebral deformities: the study of osteoporotic frac-
tures. J Bone Miner Res 1995;10(6):890e902.
23. Delmas PD, van de Langerijt L, Watts NB, Eastell R, Genant H,
Grauer A, et al. Underdiagnosis of vertebral fractures is
1172 J.D. Carter et al.a worldwide problem: the IMPACT study. J Bone Miner Res
2005;20(4):557e63.
24. Jiang G, Eastell R, Barrington NA, Ferrar L. Comparison of
methods for the visual identification of prevalent vertebral
fracture in osteoporosis. Osteoporos Int 2004;15(11):887e96.
25. Pak CY, Ho A, Poindexter J, Peterson R, Sakhaee K. Quantita-
tion of the incident spinal fractures: comparison of visual
detection with quantitative morphometry. Bone 1996;18(4):
349e53.
26. Kado DM, Browner WS, Palmero L, Nevitt MC, Genant HK,
Cummings SR. Vertebral fractures and mortality in older
women. A prospective study. Arch Intern Med 1999;159:
1215e20.
27. Genant HK, Wu CY, van Kuijk C, Nevitt MC. Vertebral fracture
assessment using a semiquantitative technique. J Bone Miner
Res 1993;8:1137e48.
28. Cobb JR. Outline for the study of scoliosis. J Am Acad Orthop
Surg 1948;5:261e75.29. Schneider DL, von Muhlen DG, Barrett-Connor E, Sartoris DJ.
Kyphosis does not equal vertebral fractures: the Rancho
Bernardo study. J Rheumatol 2004;31(4):747e52.
30. de Vries F, Bracke M, Leufkens HGM, Lammers JWJ, Cooper C,
van Staa TP. Fracture risk with intermittent high-dose oral
glucocorticoid therapy. Arthritis Rheum 2007;56(1):208e14.
31. American College of Rheumatology Ad Hoc Committee on
Glucocorticoid-Induced Osteoporosis. Recommendations for
the prevention and treatment of glucocorticoid-induced
osteoporosis: 2001 update.Arthritis Rheum 2001;44:1496e503.
32. Ensrud KE, Black DM, Harris F, Ettinger B, Cummings SR.
Correlates of kyphosis in older women. The Fracture Inter-
vention Trial Research Group. J Am Geriatr Soc 1997;45(6):
682e7.
33. Bartynski WS, Heller MT, Grahovac SZ, Rothfus WE, Kurs-
Lasky M. Severe thoracic kyphosis in the older patient in the
absence of vertebral fracture: association of extreme curve
with age. AJNR Am J Neuroradiol 2005;26(8):2077e85.
